Webinars and Sponsored Roundtables — Register Now

Tuesday, April 28, 2026, 12:00 PM–1:00 PM ET
Discover how next-day comprehensive genomic profiling (CGP) is possible with the Oncomine Comprehensive Assay Plus on the Genexus System—delivering both speed and accuracy.

Webinar presenters Jane Bayani, MHSc, PhD, Assistant Professor and Co-Director, Diagnostic Development, Ontario Institute for Cancer Research, Canada, and Nicola Normanno, MD, Scientific Director, IRCCS Romagnolo Institute for the Study of Tumors, Italy, and Morten Grauslund, PhD, Molecular Biologist, Department of Pathology, Rigshospitalet/Copenhagen University Hospital, Copenhagen, Denmark.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Thermo Fisher Scientific. For Research Use Only. Not for use in diagnostic applications. 

Thursday, April 30, 2026, 11:00 AM–12:00 PM ET
Hear an expert discuss how Memorial Sloan Kettering Cancer Center (MSKCC) is utilizing
the oncoReveal® Nexus 21-gene panel to redefine turnaround time and actionable insights
in cancer care. Dr. Ewalt shares a perceptive look at the clinical need for rapid, front-line NGS sequencing, and how a unique, purpose built targeted NGS panel (Pillar Biosciences’ oncoReveal Nexus 21 gene Panel) was developed, validated and implemented clinically by Memorial Sloan Kettering Cancer Center (MSK-REACT) to complement their current comprehensive genomic profiling (CGP) approach.

Webinar presenter Mark Ewalt, MD, Associate Medical Director for Laboratory Operations for Diagnostic Molecular Pathology in the Molecular Diagnostics Service, Department of Pathology and Laboratory Medicine, MSKCC.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Pillar Biosciences.

Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.

Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy,  CEO of mTuitive.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Subspecialties

Interactive Product Guides

Product Spotlight

Thermo Fisher Scientific

Ion GeneStudio S5 System

Company

Thermo Fisher Scientific

Name of system

Ion GeneStudio S5 System

Email

[email protected]

City, State

Carlsbad, CA

Phone

800-955-6288

Website

https://www.thermofisher.com/genestudio

System application/FDA cleared or approved

research use/not required

Country where designed/Manufactured

U.S./Singapore

First year sold in U.S./First year installed in U.S.

2018/2018

System sold internationally

yes (worldwide)

Dimensions of sequencer (H × W × D)/Footprint of sequencer

62.5 × 34.0 × 36.7 in./8.7 sq. ft.

Accessory equipment supplied with sequencer at no cost

Type of computer supplied with sequencer

operating computer

Analysis options provided with sequencer

onboard, cloud based, local server

Where library preparation is performed

accessory equipment

Bioinformatics tools provided with sequencer

onboard, cloud based, local server

Sequencer supplied with UPS (uninterruptible power supply)

no

Electrical connection required for sequencer

100–240 VAC at 50/60 Hz, 6.5–14.5 A

List price of entire sequencer and necessary components

Purchase options

purchase, trade in, lease, finance

Warranties offered

first year included with purchase; extended warranty available

Training included/Total time for basic training per operator

yes/1 day

Training location/Follow-up training available

at vendor office or customer site/yes (extra charge)

Maximum No. of samples amplified in a single amplification event

384 samples (>384 samples with custom barcodes)

Read length/Percent bases >Q30

Paired-end capability/Tag lengths/Spans

Fragment/Tag lengths/Spans

yes/—/up to 600 bp

Mate pair/Tag lengths/Spans

Single end/Tag lengths/Spans

yes/—/up to 400 bp

RNA sequencing/Tag lengths/Spans

yes/—/up to 400 bp

ChIP sequencing/Tag lengths/Spans

Bisulfite sequencing/Tag lengths/Spans

yes/—/up to 400 bp

Maximum No. of reads or fragments sequenced per single-end run

2–130 million

Maximum No. of reads or fragments sequenced per paired-end run

Total No. of nucleotides (bases) sequenced per run

20–25 Gb (Ion 550); 10–15 Gb (Ion 540); 3–4 Gb (Ion 530); 0.6–1 Gb (Ion 520); 0.3–0.5 Gb (Ion 510 chip)

Wet lab bench time for sequencing preparation

<45 minutes

Sequencing run time

2.5–4 hours

Total time for generating standard gDNA library

• Paired end

• Fragment

4–6 hours

• Paired end

• Fragment

• Mate pair

• Single end

5–7 hours

• RNA sequencing

<6 hours

• ChIP sequencing

• Bisulfite sequencing

5.5 hours

Library preparation integrated in system as standard offering

yes (Ion Chef)

Library preparation offered separately for additional charge

yes (Ion AmpliSeq kit for Chef DL8)

Cost of sequencing reagents per run

Reagent tracking method

RFID

• Type of reagent information tracked

expiration date, lot and part Nos.

Shipping conditions for amplification/sequencing reagents

20°C, 4°C, ambient (variable based on product)/20°C, 4°C, ambient (variable based on product)

Storage conditions for amplification/sequencing reagents

20°C, 4°C, ambient (variable based on product)/20°C, 4°C, ambient (variable based on product)

Shelf life of amplification/sequencing reagents

12–36 months from manufacture date (variable based on product)/12–36 months from manufacture date (variable based on product)

System requires a control sample on sequencing run 

optional

• Company offers a sequencing control

yes (additional charge)

Sequencing system control software and devices to start run/for data analysis

Torrent Suite/Ion Reporter

Complete walkaway automation for amplification, sequencing, and variant calling

no (walkaway automation for sequencing, variant calling)

Remote system monitoring

Total time required for setup of amplification, sequencing, and variant calling steps

<30 minutes

Maximum No. of libraries sequenced in a single run

384 samples

System includes secondary data-analysis software developed by company

yes (Torrent Suite, Ion Reporter)

System includes post-sequencing data-analysis software

yes (Torrent Suite, Ion Reporter)

Mutations detectable via data-analysis software

substitutions, indels, copy number changes, complex biomarkers MSI, TMB, HRD

System can generate a variant report

yes

Types of maintenance plans available/mean time between failures

AB Assurance/—

No. of field application scientists and engineers based in U.S.

450

• Weekly

• Monthly

• Pre-run

Distinguishing features of NGS system (supplied by company)Note: a dash in lieu of an answer means company did not answer question or question is not applicable

pre-prepared library to variant report in <24 hours with 30 minutes of hands-on time; start with as little as 1 ng of input DNA; flexible sequencing depth and sample number throughput

More products
in this guide

MiSeq i100 Plus
NextSeq 550Dx
NextSeq 1000; NextSeq 2000
NovaSeq 6000Dx
NovaSeq X; NovaSeq X Plus
Ion Torrent Genexus Integrated Sequencer; Ion Torrent Genexus Dx Integrated Sequencer